Can a virtual program and wearable sensor tame type 2 diabetes?

NCT ID NCT07743307

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether combining a virtual diabetes self-management program with continuous glucose monitoring is practical and well-liked by adults with type 2 diabetes. Twenty participants will attend a 9-week virtual program and wear a glucose sensor for up to 22 weeks to track blood sugar. They will fill out questionnaires and have blood drawn to measure long-term blood sugar control. The goal is to see if this integrated approach could lead to better diabetes management and improved health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A virtual diabetes self-management program (DECIDE) combined with continuous glucose monitoring (Freestyle Libre)
What this could lead to
If this approach proves practical and acceptable, it could lead to a new way to help adults with type 2 diabetes better manage their blood sugar and improve health outcomes.
What could go wrong
This is a small feasibility study with only 20 participants, so results may not apply broadly. The program requires consistent participation and CGM use, which may be challenging for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northwell Heath

    Manhasset, New York, 11030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.